In reply to the Letter to Editor regarding "Evaluation of tetracycline and fluoroquinolone therapy against Japanese spotted fever: Analysis based on individual data from case reports and case series"

Int J Antimicrob Agents. 2024 Aug;64(2):107246. doi: 10.1016/j.ijantimicag.2024.107246. Epub 2024 Jun 20.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents* / therapeutic use
  • Fluoroquinolones* / therapeutic use
  • Humans
  • Spotted Fever Group Rickettsiosis / drug therapy
  • Tetracycline* / therapeutic use

Substances

  • Fluoroquinolones
  • Anti-Bacterial Agents
  • Tetracycline